Effectiveness and safety of nivolumab and ipilimumab in older adults with renal cell carcinoma: findings from a multicenter observational study in Poland
This study demonstrates that nivo+ipi are effective across age groups, with older patients achieving comparable or even superior outcomes with acceptable irAEs rates.
Authors
- Renata Pacholczak‐Madej (ORCID: https://orcid.org/0000-0002-6535-4841)
- Angelika Gawlik-Urban (ORCID: https://orcid.org/0000-0003-1396-1196)
- Artur Drobniak
- Mirosława Püsküllüoğlu (ORCID: https://orcid.org/0000-0002-2647-9625)
- Aleksandra Grela-Wojewoda (ORCID: https://orcid.org/0000-0002-6727-8926)
- Jacek Calik (ORCID: https://orcid.org/0000-0002-4492-8551)
- Agnieszka Roman
- Jolanta Dobrzańska
- Łukasz Stokłosa
- Anna Bidas
- Daria Tusień-Małecka
- Marek Szwiec
- Natalia Versuti Viegas
Institutions
- Poznan University of Medical Sciences (PL)
- Jagiellonian University (PL)
- University of Wrocław (PL)
- Akademia Tarnowska (PL)
- Ludwik Solski Academy for the Dramatic Arts (PL)
- University College of Tourism and Ecology (PL)
- Podhale State Higher Vocational School in Nowy Targ (PL)
- National Institute of Oncology (HU)
- Holy Cross University (PL)
- Krakow Cardiovascular Research Institute (PL)
- University of Zielona Góra (PL)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-08-19
- DOI
- https://doi.org/10.3389/fonc.2025.1617743
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00